Characterization and Development of a Peptide (p160) with Affinity for Neuroblastoma Cells

Drug-targeting strategies can increase the efficacy and reduce the side effects and toxicity of conventional chemotherapy or may lead to new radiolabeled molecules useful for diagnosis and therapy. To identify and characterize new carrier molecules, we evaluated a peptide that had been identified by...

Ausführliche Beschreibung